Found: 17
Select item for more details and to access through your institution.
Efficacy and safety of ritlecitinib in adolescents with alopecia areata: Results from the ALLEGRO phase 2b/3 randomized, double‐blind, placebo‐controlled trial.
- Published in:
- Pediatric Dermatology, 2023, v. 40, n. 6, p. 1003, doi. 10.1111/pde.15378
- By:
- Publication type:
- Article
Impact of Crisaborole on Sleep Outcomes in Pediatric Patients with Mild-to-Moderate Atopic Dermatitis.
- Published in:
- Dermatology & Therapy, 2023, v. 13, n. 4, p. 951, doi. 10.1007/s13555-023-00899-y
- By:
- Publication type:
- Article
Efficacy and safety of tofacitinib by background methotrexate dose in psoriatic arthritis: post hoc exploratory analysis from two phase III trials.
- Published in:
- Clinical Rheumatology, 2022, v. 41, n. 2, p. 499, doi. 10.1007/s10067-021-05894-2
- By:
- Publication type:
- Article
Efficacy and Safety Trends with Continuous, Long-Term Crisaborole Use in Patients Aged ≥ 2 Years with Mild-to-Moderate Atopic Dermatitis.
- Published in:
- Dermatology & Therapy, 2021, v. 11, n. 5, p. 1667, doi. 10.1007/s13555-021-00584-y
- By:
- Publication type:
- Article
Correction to: Efficacy and Safety Trends with Continuous, Long-Term Crisaborole Use in Patients Aged ≥ 2 Years with Mild-to-Moderate Atopic Dermatitis.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Efficacy and safety of crisaborole in patients with mild-tomoderate atopic dermatitis and other atopic comorbidities.
- Published in:
- Allergy & Asthma Proceedings, 2021, v. 42, n. 5, p. 425, doi. 10.2500/aap.2021.42.210064
- By:
- Publication type:
- Article
Re-establishment of efficacy of tofacitinib, an oral JAK inhibitor, after temporary discontinuation in patients with rheumatoid arthritis.
- Published in:
- Clinical Rheumatology, 2020, v. 39, n. 7, p. 2127, doi. 10.1007/s10067-020-04956-1
- By:
- Publication type:
- Article
Safety, Effectiveness, and Pharmacokinetics of Crisaborole in Infants Aged 3 to < 24 Months with Mild-to-Moderate Atopic Dermatitis: A Phase IV Open-Label Study (CrisADe CARE 1).
- Published in:
- American Journal of Clinical Dermatology, 2020, v. 21, n. 2, p. 275, doi. 10.1007/s40257-020-00510-6
- By:
- Publication type:
- Article
Live Zoster Vaccine in Patients With Rheumatoid Arthritis Treated With Tofacitinib With or Without Methotrexate, or Adalimumab With Methotrexate: A Post Hoc Analysis of Data From a Phase IIIb/IV Randomized Study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Real-World Comparative Effectiveness of Tofacitinib and Tumor Necrosis Factor Inhibitors as Monotherapy and Combination Therapy for Treatment of Rheumatoid Arthritis.
- Published in:
- Rheumatology & Therapy, 2019, v. 6, n. 4, p. 573, doi. 10.1007/s40744-019-00177-4
- By:
- Publication type:
- Article
Evaluation of disease activity in patients with rheumatoid arthritis treated with tofacitinib by RAPID3: post hoc analyses from two phase 3 trials.
- Published in:
- Clinical Rheumatology, 2018, v. 37, n. 8, p. 2043, doi. 10.1007/s10067-018-4077-3
- By:
- Publication type:
- Article
Effect of Discontinuation or Initiation of Methotrexate or Glucocorticoids on Tofacitinib Efficacy in Patients with Rheumatoid Arthritis: A Post Hoc Analysis.
- Published in:
- Rheumatology & Therapy, 2018, v. 5, n. 1, p. 203, doi. 10.1007/s40744-018-0093-7
- By:
- Publication type:
- Article
Switching from adalimumab to tofacitinib in the treatment of patients with rheumatoid arthritis.
- Published in:
- Arthritis Research & Therapy, 2016, v. 18, p. 1, doi. 10.1186/s13075-016-1049-3
- By:
- Publication type:
- Article
Safety and Efficacy of Eletriptan in the Treatment of Acute Migraine.
- Published in:
- Pharmacotherapy, 2006, v. 26, n. 1, p. 115, doi. 10.1592/phco.2006.26.1.115
- By:
- Publication type:
- Article
Meta-analysis of trials of interventions to improve medication adherence.
- Published in:
- American Journal of Health-System Pharmacy, 2003, v. 60, n. 7, p. 657, doi. 10.1093/ajhp/60.7.657
- By:
- Publication type:
- Article
Meta-Analysis of Interventions To Improve Drug Adherence in Patients with Hyperlipidemia.
- Published in:
- Pharmacotherapy, 2003, v. 23, n. 1, p. 80, doi. 10.1592/phco.23.1.80.31921
- By:
- Publication type:
- Article
Nonsteroidal anti-inflammatory drugs: Review of factors guiding formularly selection.
- Published in:
- Formulary, 2000, v. 35, n. 2, p. 142
- By:
- Publication type:
- Article